Home > Press > Accelrys Announces Date of Third Quarter Fiscal 2007 Financial Results and Conference Call
Abstract:
Accelrys, Inc. (NASDAQ:ACCL) today announced that it will report financial results for the quarter ended December 31, 2006 after the NASDAQ Market closes on Thursday, February 1, 2007. The Company will conduct a conference call and an audio webcast at 5:00 p.m. ET on the same day.
Conference Call Information
Domestic callers: 1 866-831-6243
International callers: +1 617-213-8855
Passcode: 11083271
Webcast information: http://ir.accelrys.com/
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).
A replay of the conference call, which can be accessed by dialing toll-free 1-888-286-8010, and outside the U.S. +1-617-801-6888, will be available beginning 7:00 p.m. ET on February 1, 2007 through 5:00 p.m. ET on May 1, 2007. The access code for the replay is 37598796.
####
About About Accelrys, Inc.
Accelrys, Inc. (ACCL) is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers for product design as well as drug discovery and development. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The Company is headquartered in San Diego, California. Its materials research and development team is based at its European Headquarters and Centre of Excellence in Cambridge, UK. For more information see http://www.accelrys.com/ .
For more information, please click here
Contacts:
Accelrys, Inc.
Rick Russo, 858-799-5200
Copyright © Business Wire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||